Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Suggestion for HIV drug testing

Discussion in 'XMRV Testing, Treatment and Transmission' started by Andrew, Apr 7, 2010.

  1. Andrew

    Andrew Senior Member

    Messages:
    2,185
    Likes:
    2,351
    Los Angeles, USA
    I don't know who to email this too. Maybe someone else can act on this. It seems to me that the first HIV drug they should test would be the one with the least amount of side effects, In fact, it could also be one of the ones that is not the most effective with HIV. For all we know, it might be effective with XMRV.

    OTOH, if drug companies test, I guess we have no choice. But maybe Klimas (who knows about AIDS drugs) could team up with Singh (who is testing drugs) and maybe good things could happen.
     
  2. Kati

    Kati Patient in training

    Messages:
    5,424
    Likes:
    19,311
    Andrew, they are smart people- they know what to do!
     
  3. Andrew

    Andrew Senior Member

    Messages:
    2,185
    Likes:
    2,351
    Los Angeles, USA
    If Raltegravir and AZT are examples of the lowest risk HIV drugs out there, I guess I'll have to wait for a new drug to come out.
     
  4. Hope123

    Hope123 Senior Member

    Messages:
    1,235
    Likes:
    1,000
    An intermediate step might be to isolate XMRV from positive CFS sufferers and test that first in vitro rather than have people just take antiretrovirals. As far as I understand, to date XMRV tested has not been that from folks with CFS but from lab stock. Since we know so very little about XMRV at the moment, it would make sense to test isolated XMRV rather than assume XMRV from sufferers are the same as lab stock. The analogy is testing different antibiotics against isolated bacteria from a sick patient in the lab to narrow down which antibiotics work and at which dose before giving them to the patient. This latter process is done all the time when treating patients with serious bacterial infections.
     

See more popular forum discussions.

Share This Page